Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam S Olia

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Biorxiv : the Preprint Server for Biology|June 9, 2022
Potent and pan-neutralization of SARS-CoV-2 variants of concern by DARPinsVikas Chonira, Young Do Kwon, Jason Gorman, et al.
Cell Reports|July 19, 2024
Design of soluble HIV-1 envelope trimers free of covalent gp120-gp41 bonds with prevalent native-like conformationPeng Zhang, Jason Gorman, Yaroslav Tsybovsky, et al.
Frontiers in Immunology|June 14, 2024
Anti-idiotype isolation of a broad and potent influenza A virus-neutralizing human antibodyAdam S Olia, Madhu Prabhakaran, Darcy R Harris, et al.
The Journal of Biological Chemistry|August 30, 2021
SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicityAdam S Olia, Yaroslav Tsybovsky, Steven J Chen, et al.
Nature Microbiology|February 6, 2024
A non-human primate model for human norovirus infectionInga Rimkute, Natthawan Chaimongkol, Kamron D Woods, et al.
Structure (London, England : 1993)|April 30, 2022
Structure of an influenza group 2-neutralizing antibody targeting the hemagglutinin stem supersiteCrystal Sao-Fong Cheung, Jason Gorman, Sarah F Andrews, et al.
Nature Chemical Biology|November 21, 2022
A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPinsVikas Chonira, Young D Kwon, Jason Gorman, et al.
Structure (London, England : 1993)|August 15, 2025
The N terminus of H3-influenza hemagglutinin as a site-of-vulnerability to neutralizing antibodyReda Rawi, Nicholas C Morano, Crystal Sao-Fong Cheung, et al.
Vaccines|January 22, 2024
Extraordinary Titer and Broad Anti-SARS-CoV-2 Neutralization Induced by Stabilized RBD Nanoparticles from Strain BA.5Zhantong Wang, Baoshan Zhang, Li Ou, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Multimeric nanobodies from camelid engineered mice and llamas potently neutralize SARS-CoV-2 variantsJianliang Xu, Kai Xu, Seolkyoung Jung, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Biorxiv : the Preprint Server for Biology|June 9, 2022
Potent and pan-neutralization of SARS-CoV-2 variants of concern by DARPinsVikas Chonira, Young Do Kwon, Jason Gorman, et al.
Cell Reports|July 19, 2024
Design of soluble HIV-1 envelope trimers free of covalent gp120-gp41 bonds with prevalent native-like conformationPeng Zhang, Jason Gorman, Yaroslav Tsybovsky, et al.
Frontiers in Immunology|June 14, 2024
Anti-idiotype isolation of a broad and potent influenza A virus-neutralizing human antibodyAdam S Olia, Madhu Prabhakaran, Darcy R Harris, et al.
The Journal of Biological Chemistry|August 30, 2021
SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicityAdam S Olia, Yaroslav Tsybovsky, Steven J Chen, et al.
Nature Microbiology|February 6, 2024
A non-human primate model for human norovirus infectionInga Rimkute, Natthawan Chaimongkol, Kamron D Woods, et al.
Structure (London, England : 1993)|April 30, 2022
Structure of an influenza group 2-neutralizing antibody targeting the hemagglutinin stem supersiteCrystal Sao-Fong Cheung, Jason Gorman, Sarah F Andrews, et al.
Nature Chemical Biology|November 21, 2022
A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPinsVikas Chonira, Young D Kwon, Jason Gorman, et al.
Structure (London, England : 1993)|August 15, 2025
The N terminus of H3-influenza hemagglutinin as a site-of-vulnerability to neutralizing antibodyReda Rawi, Nicholas C Morano, Crystal Sao-Fong Cheung, et al.
Vaccines|January 22, 2024
Extraordinary Titer and Broad Anti-SARS-CoV-2 Neutralization Induced by Stabilized RBD Nanoparticles from Strain BA.5Zhantong Wang, Baoshan Zhang, Li Ou, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Multimeric nanobodies from camelid engineered mice and llamas potently neutralize SARS-CoV-2 variantsJianliang Xu, Kai Xu, Seolkyoung Jung, et al.
Pageof 8